Latest Ratios: P/E Ratio 14.0x · EV/EBITDA 9.2x · ROE 7.0%. (2010–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $258M | $238M | $228M | $229M | $205M | $200M | $161M | $217M | $192M | $199M | $138M |
| Enterprise Value | $243M | $223M | $217M | $219M | $206M | $206M | $112M | $160M | $276M | $116M | $230M |
| P/E Ratio → | 13.99 | 12.80 | 22.21 | 8.91 | 7.72 | 8.89 | 11.65 | 21.42 | 13.04 | 18.07 | 11.62 |
| P/S Ratio | 1.86 | 1.71 | 1.74 | 2.18 | 2.59 | 2.70 | 2.42 | 3.44 | 3.39 | 3.91 | 2.88 |
| P/B Ratio | 0.96 | 0.88 | 0.87 | 0.95 | 0.93 | 0.92 | 0.77 | 1.11 | 1.04 | 1.18 | 1.33 |
| P/FCF | 12.53 | 11.55 | 17.26 | 10.72 | 8.75 | 17.07 | 10.72 | 16.60 | 11.94 | 15.70 | 10.14 |
| P/OCF | 12.01 | 11.07 | 15.47 | 9.92 | 8.53 | 15.49 | 8.88 | 12.73 | 11.26 | 15.52 | 10.13 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.60 | 1.66 | 2.08 | 2.61 | 2.79 | 1.69 | 2.53 | 4.89 | 2.28 | 4.82 |
| EV / EBITDA | 9.23 | 8.46 | 14.39 | 6.78 | 5.71 | 6.63 | 5.86 | 11.75 | 15.05 | 7.39 | 13.34 |
| EV / EBIT | 10.26 | 9.41 | 16.95 | 7.22 | 6.05 | 7.07 | 6.50 | 12.97 | 15.59 | 7.80 | 14.12 |
| EV / FCF | — | 10.82 | 16.45 | 10.24 | 8.81 | 17.62 | 7.49 | 12.20 | 17.19 | 9.16 | 16.96 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 55.8% | 55.8% | 53.1% | 65.6% | 91.9% | 86.1% | 72.8% | 63.4% | 75.2% | 75.2% | 83.8% |
| Operating Margin | 17.0% | 17.0% | 9.8% | 28.8% | 43.1% | 39.5% | 26.0% | 19.5% | 31.3% | 29.3% | 34.1% |
| Net Profit Margin | 13.4% | 13.4% | 7.8% | 24.4% | 33.6% | 30.4% | 20.8% | 16.1% | 26.0% | 21.7% | 24.8% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 7.0% | 7.0% | 4.1% | 11.2% | 12.1% | 10.6% | 6.8% | 5.3% | 8.3% | 8.1% | 12.2% |
| ROA | 0.8% | 0.8% | 0.5% | 1.5% | 1.6% | 1.4% | 0.9% | 0.7% | 1.2% | 1.0% | 1.2% |
| ROIC | 6.2% | 6.2% | 3.5% | 8.9% | 10.6% | 9.5% | 5.9% | 3.6% | 5.7% | 5.8% | 4.3% |
| ROCE | 8.0% | 8.0% | 4.5% | 11.6% | 13.8% | 12.3% | 7.7% | 6.2% | 10.0% | 10.9% | 16.7% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.08 | 0.08 | 0.09 | 0.10 | 0.12 | 0.09 | 0.09 | 0.08 | 0.60 | — | 1.08 |
| Debt / EBITDA | 0.80 | 0.80 | 1.52 | 0.75 | 0.74 | 0.60 | 0.99 | 1.11 | 6.04 | — | 6.50 |
| Net Debt / Equity | — | -0.06 | -0.04 | -0.04 | 0.01 | 0.03 | -0.23 | -0.29 | 0.46 | -0.49 | 0.89 |
| Net Debt / EBITDA | -0.58 | -0.58 | -0.71 | -0.32 | 0.04 | 0.21 | -2.53 | -4.24 | 4.60 | -5.28 | 5.37 |
| Debt / FCF | — | -0.74 | -0.81 | -0.48 | 0.06 | 0.56 | -3.23 | -4.40 | 5.26 | -6.54 | 6.82 |
| Interest Coverage | 0.43 | 0.43 | 0.23 | 0.91 | 5.68 | 4.37 | 1.35 | 0.67 | 1.33 | 1.68 | 2.10 |
Net cash position: cash ($36M) exceeds total debt ($21M)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.09 | 0.09 | 0.12 | 0.08 | 0.08 | 0.08 | 0.11 | 0.15 | 0.11 | 0.18 | 0.15 |
| Quick Ratio | 0.09 | 0.09 | 0.12 | 0.08 | 0.08 | 0.08 | 0.11 | 0.15 | 0.11 | 0.18 | 0.15 |
| Cash Ratio | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.05 | 0.06 | 0.02 | 0.08 | 0.02 |
| Asset Turnover | — | 0.06 | 0.06 | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | 0.05 | 0.04 | 0.05 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 3.3% | 3.6% | 3.3% | 3.2% | 3.2% | 2.2% | 1.7% | 0.6% | 0.1% | — | — |
| Payout Ratio | 46.6% | 46.6% | 74.3% | 28.9% | 24.4% | 19.5% | 19.6% | 12.6% | 1.4% | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 7.2% | 7.8% | 4.5% | 11.2% | 13.0% | 11.3% | 8.6% | 4.7% | 7.7% | 5.5% | 8.6% |
| FCF Yield | 8.0% | 8.7% | 5.8% | 9.3% | 11.4% | 5.9% | 9.3% | 6.0% | 8.4% | 6.4% | 9.9% |
| Buyback Yield | 3.0% | 3.3% | 0.4% | 0.0% | 4.6% | 5.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 6.4% | 6.9% | 3.7% | 3.2% | 7.8% | 7.2% | 1.7% | 0.6% | 0.1% | 0.0% | 0.0% |
| Shares Outstanding | — | $7M | $7M | $6M | $6M | $7M | $7M | $7M | $7M | $6M | $5M |
CRE concentration refinance risk
Based on recent market data, BPRN trades at a P/B ratio of 0.96, which suggests that investors are pricing the bank at a discount to its tangible book value, reflecting skepticism regarding the long-term earnings power of its concentrated commercial real estate loan portfolio.
The current P/B multiple below parity indicates that the market is not yet assigning a premium to the bank's Princeton-centric franchise. This valuation level implies that investors are demanding a higher margin of safety, likely due to the potential for credit migration within the CRE segment that could erode tangible book value over time.
According to quarterly financial data, BPRN's ROE has struggled to exceed 2.4% over the last ten quarters, indicating that the bank's profitability is currently constrained by a combination of thin net interest margins and the necessity of maintaining higher capital buffers against its loan book.
The DuPont decomposition suggests that the bank's profitability is hampered by low asset utilization and a lack of significant non-interest income contribution. Investors should monitor whether management can improve the efficiency ratio, as the current ROE levels appear insufficient to cover the cost of equity in a normalized interest rate environment.
As reported in financial statements, BPRN's efficiency ratio has fluctuated significantly, reaching a high of 59.5% in 2024Q3 before stabilizing near 40.0%, which highlights the operational challenges of maintaining profitability while funding costs remain elevated relative to the bank's core asset yields.
The persistent 0.8% NIM observed over the last ten quarters suggests that the bank lacks the pricing power to pass on higher deposit costs to its commercial borrowers. This structural limitation implies that any further increase in funding costs could lead to immediate margin compression unless the bank successfully shifts its deposit mix toward lower-cost core accounts.
Based on reported figures, BPRN has maintained a consistent equity-to-assets ratio of approximately 0.12, providing a stable regulatory capital foundation that appears adequate to absorb potential credit losses within its concentrated commercial real estate and multi-family loan portfolios during the current economic cycle.
The bank's commitment to maintaining this capital level suggests a conservative approach to balance sheet management, which may limit near-term growth but enhances long-term stability. This capital position warrants further investigation to determine if it provides sufficient flexibility for opportunistic lending or if it will remain tied up in defensive provisioning.
The market's reliance on P/E multiples for BPRN is fundamentally flawed, as reported earnings are frequently distorted by lumpy loan loss provisions under CECL accounting, which obscures the bank's true core earnings power and makes the P/E ratio a volatile and unreliable indicator of value.
Investors should instead focus on P/TBV and pre-provision net revenue (PPNR) to better assess the bank's underlying performance. Relying on P/E ratios in this context risks misinterpreting temporary accounting charges as permanent declines in franchise value, leading to potentially incorrect investment conclusions regarding the bank's long-term profitability.
Includes 30+ ratios · 16 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying BPRN stock.
Princeton Bancorp, Inc.'s current P/E ratio is 14.0x. The historical average is 13.6x. This places it at the 70th percentile of its historical range.
Princeton Bancorp, Inc.'s current EV/EBITDA is 9.2x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 9.5x.
Princeton Bancorp, Inc.'s return on equity (ROE) is 7.0%. The historical average is 9.2%.
Based on historical data, Princeton Bancorp, Inc. is trading at a P/E of 14.0x. This is at the 70th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Princeton Bancorp, Inc.'s current dividend yield is 3.33% with a payout ratio of 46.6%.
Princeton Bancorp, Inc. has 55.8% gross margin and 17.0% operating margin. Operating margin between 10-20% is typical for established companies.
Princeton Bancorp, Inc.'s Debt/EBITDA ratio is 0.8x, indicating low leverage. A ratio below 2x is generally considered financially healthy.